Breast Cancer: Recurrent Genomic Alterations: Difference between revisions

[unchecked revision][unchecked revision]
mNo edit summary
No edit summary
Line 93: Line 93:
|PARP inhibitors (germline)
|PARP inhibitors (germline)
|-
|-
|''[[BRCA1 syndrome|BRCA1]], [[BRCA2 syndrome|BRCA2]]''
|''[[BRCA1]], [[BRCA2]]''
|1
|1
|Often hereditary risk; TNBC
|Often hereditary risk; TNBC